Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 315545 · PVCT

Provectus Biopharmaceuticals, Inc.

Filing with the SEC SEC-reporting company Knoxville, TN OTC
An email when it files something new with the SEC. Your account

What this means

  • Stockholders’ deficitAt the end of 2025 total liabilities exceeded total assets: stockholders’ equity was −$6.3M (XBRL data filed with the SEC).
  • Revenue downRevenue fell from $617K in 2024 to $336K in 2025 (46% lower).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$336K$617K
Net income (loss)$5.5M$4.8M
Total assets$698K$1M
Total liabilities$7M$7M
Stockholders’ equity−$6.3M−$6M
Cash and equivalents$251K$307K

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
PROVECTUS BIOPHARMACEUTICALS, INC.
Formerly: Provectus Pharmaceuticals Inc
CIK
0000315545
Tickers
PVCT
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
Knoxville, Tennessee
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 10, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 10, 2026 · filing · edition of Nov 10, 2026
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 13, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jul 1, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 14, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 26, 2026 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Dec 8, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 13, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 14, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 14, 2025 · filing
  • Change of auditor
    Form 8-K · items 4.01, 9.01 · filed Apr 16, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 28, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Dec 5, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 12, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Aug 19, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 13, 2024 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Jul 17, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Jul 3, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 14, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Apr 16, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Mar 28, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Mar 26, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 14, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 14, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 11, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Mar 30, 2023 · filing